Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Ovid Therapeutics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 59 | 60 | +1 |
| Shares | 35.6M | 38.6M | +2.97M (+8.3%) |
| Value | $65.5M | $71.7M | +$6.23M (+9.5%) |
New holders (9)
Institutions that held Ovid Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TLS Advisors LLC | 1,490,534 | $2.77M | 13.66% |
| Jacobs Levy Equity Management, Inc | 166,041 | $308.8K | 0.00% |
| Tejara Capital Ltd | 107,491 | $199.9K | 0.12% |
| Ergoteles LLC | 75,923 | $141.2K | 0.01% |
| Citadel Advisors LLC | 38,028 | $70.7K | 0.00% |
| ExodusPoint Capital Management, LP | 13,392 | $25.0K | 0.00% |
| Susquehanna International Group, LLP | 12,049 | $22.4K | 0.00% |
| Tri Locum Partners LP | 10,009 | $19.0K | 0.01% |
| ICA Group Wealth Management, LLC | 55 | $102 | 0.00% |
Sold out (8)
Institutions that held Ovid Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Stonepine Capital Management, LLC | 1,540,671 | $2.83M |
| Balyasny Asset Management LLC | 31,938 | $59.0K |
| American Century Companies Inc | 10,071 | $19.0K |
| Virtu Financial LLC | 10,347 | $19.0K |
| The PNC Financial Services Group, Inc. | 2,000 | $4.00K |
| Group One Trading, L.P. | 1,532 | $3.00K |
| China Universal Asset Management Co., Ltd. | 660 | $1.00K |
| Daiwa Securities Group Inc. | 119 | $0 |